Time-dependent efficacy of seven pharmacological regimens for ulcer healing and delayed bleeding prevention after gastric endoscopic submucosal dissection: A frequentist network meta-analysis
- 1Department of Gastroenterology, Tongxiang Hospital of Traditional Chinese Medicine, Tongxiang City, Zhejiang Province, China.
- 2Department of Urology, Jinshan District Central Hospital affiliated to Shanghai University of Medicine & Health Sciences, Jinshan Branch of Shanghai Sixth People's Hospital, Jinshan District, Shanghai, China.
Abstract
Background: Gastric ESD induces large mucosal defects with potential delayed complications, including bleeding and perforation. The comparative efficacy of pharmacological regimens—PPI, P-CAB, H2RA, MP, and their combinations—remains unclear. Methods: We conducted a frequentist network meta-analysis of 31 randomized controlled trials evaluating seven pharmacological strategies for post-ESD ulcer healing and delayed bleeding prevention. Outcomes were assessed at 4 and 8 weeks for mucosal healing and ulcer reduction, and across the treatment course for delayed bleeding/perforation. Odds ratios (ORs), mean differences (MDs), and P-scores were calculated. Heterogeneity, inconsistency, sensitivity, and publication bias were assessed. Transitivity was evaluated qualitatively, and certainty of evidence was rated using the GRADE framework. Results: At 4 weeks, the point estimate for P-CAB monotherapy favored PPI (OR=1.61, 95%CI 0.96–2.68, P = 0.069), but the confidence interval included the null value and the difference was not statistically significant; P-CAB had the highest numerical P-score ranking; combination regimens (PPI + MP, P-CAB + MP) also yielded numerically better healing outcomes. At 8 weeks, PPI + MP had the highest numerical P-score ranking, though no regimen achieved statistically superior healing compared with PPI. For delayed bleeding and perforation, all regimens demonstrated comparable safety profiles, while H2RA-based treatments showed a non-significant trend toward higher complication risk. Most pairwise comparisons were supported by low-to-moderate certainty evidence. Conclusions: While P-CAB-based regimens and MP combinations showed numerically favorable trends for early post-ESD ulcer healing, all comparative findings are limited by mostly low-to-moderate GRADE evidence certainty, and no regimen exhibited statistically significant superiority for ulcer healing. No regimen significantly reduces delayed bleeding or perforation risk.
Related
- Using Joint Models in Phase I Dose‐Finding Designs in Oncology: Considerations for Frequentist Approaches
- Frequentist prediction intervals for random-effects meta-analysis via confidence-distribution propagation
- RECAP: Representation-Based Calibration with Amortized Pooling for Frequentist Simulation-Based Inference
- Inconsistency between Frequentist and Bayesian inference, approximation of improper priors and permissible priors
- Frequentist and Bayesian population pharmacometrics: similarities, differences, and practical implications
BibTeX
@article{li2026timedependent,
title = {{Time-dependent efficacy of seven pharmacological regimens for ulcer healing and delayed bleeding prevention after gastric endoscopic submucosal dissection: A frequentist network meta-analysis}},
author = {Linqiang Li and Xiaowei Zhu and Hengda Hu},
journal = {PLOS One},
year = {2026},
month = nov,
doi = {10.1371/journal.pone.0362119},
url = {https://doi.org/10.1371/journal.pone.0362119},
note = {CC BY},
}
RIS
TY - JOUR
TI - Time-dependent efficacy of seven pharmacological regimens for ulcer healing and delayed bleeding prevention after gastric endoscopic submucosal dissection: A frequentist network meta-analysis
AU - Linqiang Li
AU - Xiaowei Zhu
AU - Hengda Hu
PY - 2026
DA - 2026/11/10
JO - PLOS One
DO - 10.1371/journal.pone.0362119
UR - https://doi.org/10.1371/journal.pone.0362119
AB - Background: Gastric ESD induces large mucosal defects with potential delayed complications, including bleeding and perforation. The comparative efficacy of pharmacological regimens—PPI, P-CAB, H2RA, MP, and their combinations—remains unclear. Methods: We conducted a frequentist network meta-analysis of 31 randomized controlled trials evaluating seven pharmacological strategies for post-ESD ulcer healing and delayed bleeding prevention. Outcomes were assessed at 4 and 8 weeks for mucosal healing and ulcer reduction, and across the treatment course for delayed bleeding/perforation. Odds ratios (ORs), mean differences (MDs), and P-scores were calculated. Heterogeneity, inconsistency, sensitivity, and publication bias were assessed. Transitivity was evaluated qualitatively, and certainty of evidence was rated using the GRADE framework. Results: At 4 weeks, the point estimate for P-CAB monotherapy favored PPI (OR=1.61, 95%CI 0.96–2.68, P = 0.069), but the confidence interval included the null value and the difference was not statistically significant; P-CAB had the highest numerical P-score ranking; combination regimens (PPI + MP, P-CAB + MP) also yielded numerically better healing outcomes. At 8 weeks, PPI + MP had the highest numerical P-score ranking, though no regimen achieved statistically superior healing compared with PPI. For delayed bleeding and perforation, all regimens demonstrated comparable safety profiles, while H2RA-based treatments showed a non-significant trend toward higher complication risk. Most pairwise comparisons were supported by low-to-moderate certainty evidence. Conclusions: While P-CAB-based regimens and MP combinations showed numerically favorable trends for early post-ESD ulcer healing, all comparative findings are limited by mostly low-to-moderate GRADE evidence certainty, and no regimen exhibited statistically significant superiority for ulcer healing. No regimen significantly reduces delayed bleeding or perforation risk.
SN - 1932-6203
ER -